Selenoprotein S: A Therapeutic Target for Diabetes and Macroangiopathy?

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-017-0585-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Crucial Role of MafA as a Novel Therapeutic Target for Diabetes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Challenges to Hemoglobin A1c as a Therapeutic Target for Type 2 Diabetes Mellitus

Journal of General and Family Medicine
2019English

Understanding PDE4's Function in Alzheimer's Disease; A Target for Novel Therapeutic Approaches

Biochemical Society Transactions
Biochemistry
2019English

Dexamethasone-Induced Selenoprotein S Degradation Is Required for Adipogenesis

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2013English

LncRNA as a Therapeutic Target for Angiogenesis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2017English

A Therapeutic Role for Selenoprotein T in Reducing Ischemia / Reperfusion Injury in the Heart?

Acta Physiologica
Physiology
2018English

Response by Kikuchi Et Al Regarding Article, “Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target”

Circulation
Cardiovascular MedicinePhysiologyCardiology
2019English

An Ancestral Retroviral Protein Identified as a Therapeutic Target in Type-1 Diabetes

JCI insight
Medicine
2017English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy